美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	090049	001	ANDA	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL	200MG; 300MG	No	No	2009/03/30 (TA)	--	MATRIX LABS LTD	None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	090437	001	ANDA	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL	600MG; 200MG; 300MG	No	No	2009/08/12 (TA)	--	MATRIX LABS LTD	None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	091593	001	ANDA	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL	600MG	No	No	2012/02/27 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	091593	002	ANDA	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL	200MG	No	No	2012/02/27 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	091593	003	ANDA	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL	300MG	No	No	2012/02/27 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	209061	001	ANDA	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET;ORAL	600MG;200MG;300MG	No	No	2024/09/05	2024/09/05	MYLAN	Discontinued